Home › Funds › Patient Capital Management, LLC › FISV
Patient Capital Management, LLC position in FISV
FISERV INC · Consumer Discretionary
Patient Capital Management, LLC reported holding 674,201 shares of FISV (FISERV INC) in its Q3 2026 13F filing — a position valued at US$30.5M, representing 1.03% of its reported portfolio and ranking #28 among its reported holdings. Patient Capital Management, LLC has disclosed FISV holdings in 10 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Patient Capital Management, LLC's FISV position evolved
Patient Capital Management, LLC first disclosed a stake in FISV in Q3 2023 at 270,626 shares (US$30.6M). The position peaked in Q1 2026 at 968,194 shares, worth US$54.0M. Across 10 filings, Patient Capital Management, LLC increased the stake 1 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 674,201 shares valued at US$30.5M — a reduction of -279,436 shares quarter over quarter.. Notable position changes include a 31% trim in Q3 2024 (shares rose 14% over the following quarter), a 92% trim in Q4 2024 (shares rose 8% over the following quarter), a 274% increase in Q1 2026 (shares fell 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 270.63K | $30.57M | New |
| Q4 2023 | 256.68K | $34.10M | Reduce |
| Q1 2024 | 233.44K | $37.31M | Reduce |
| Q2 2024 | 191.69K | $28.57M | Reduce |
| Q3 2024 | 132.87K | $23.87M | Reduce |
| Q4 2024 | 10.04K | $2.06M | Reduce |
| Q4 2025 | 259.16K | $17.41M | New |
| Q1 2026 | 968.19K | $54.03M | Add |
| Q2 2026 | 953.64K | $46.78M | Reduce |
| Q3 2026 | 674.20K | $30.46M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About FISV and 13F data
FISV (FISERV INC) is a Consumer Discretionary company. 14 other funds we track also report a position in FISV — the largest reported positions include Dodge & Cox (US$2.46B), DODGE & COX (US$2.46B), Harris Associates (Oakmark) (US$1.09B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding FISV
- Dodge & Cox 50.19M sh · $2.46B · Q2 2026
- DODGE & COX 50.19M sh · $2.46B · Q2 2026
- Harris Associates (Oakmark) 22.21M sh · $1.09B · Q2 2026
- HARRIS ASSOCIATES L P 22.21M sh · $1.09B · Q2 2026
- First Eagle Investment Management 14.02M sh · $633.57M · Q3 2026
More on Patient Capital Management, LLC
FAQ
How long has Patient Capital Management, LLC held FISV?
Patient Capital Management, LLC has disclosed FISV holdings in 10 of the last 13 reported quarters, going back to Q3 2023.
What is Patient Capital Management, LLC's current position in FISV?
As of Q3 2026, Patient Capital Management, LLC holds 674.20K shares of FISV (FISERV INC), valued at $30.46M, representing 1.03% of its reported portfolio and ranking #28.
Has Patient Capital Management, LLC been buying or selling FISV?
In the latest 13F filing (Q3 2026), Patient Capital Management, LLC reduced its position in FISV. The position peaked in Q1 2026 at 968.19K shares.
Which other funds hold FISV?
Other major institutional holders of FISV include Dodge & Cox, DODGE & COX, Harris Associates (Oakmark), among 14 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.